NS 2028
CAS: 204326-43-2
Ref. 3D-EIA32643
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Product Information
- 1H,4H-[1,2,4]Oxadiazolo[3,4-c][1,4]benzoxazin-1-one, 8-bromo-
- 4H-8-Bromo-1,2,4-oxadiazolo(3,4-d)ben(b)(1,4)oxazin-1-one
- 8-Bromo-1H,4H-[1,2,4]oxadiazolo[3,4-c][1,4]benzoxazin-1-one
- Ns 2028
NS 2028 is an inhibitor of cyclase, a signal transduction protein that is responsible for the conversion of inactive GTP to active cGMP. NS 2028 inhibits the production of cGMP by binding to and blocking the active site on cyclase, which prevents the phosphorylation and activation of downstream cellular proteins. NS 2028 has been shown to inhibit the light-induced oxidative stress response in a human prostate cancer cell line (Du-145) by reducing intracellular calcium levels and inhibiting signal pathways that lead to mitochondrial membrane potential disruption.
Chemical properties
Technical inquiry about: 3D-EIA32643 NS 2028
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
